These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12682008)

  • 1. A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization.
    Wilczynska M; Lobov S; Ohlsson PI; Ny T
    EMBO J; 2003 Apr; 22(8):1753-61. PubMed ID: 12682008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural bases of the redox-dependent conformational switch in the serpin PAI-2.
    Lobov S; Wilczynska M; Bergström F; Johansson LB; Ny T
    J Mol Biol; 2004 Dec; 344(5):1359-68. PubMed ID: 15561148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
    Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
    Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
    Jankun J; Specht Z; Szkudlarek M; Greenfield R; Gaikwad B; Trifonov L; Vaugeois J; Aleem AM; Basrur V; Selman SH; Zavodszky MI; Skrzypczak-Jankun E
    Int J Mol Med; 2006 Mar; 17(3):437-47. PubMed ID: 16465390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.
    Pedersen KE; Einholm AP; Christensen A; Schack L; Wind T; Kenney JM; Andreasen PA
    Biochem J; 2003 Jun; 372(Pt 3):747-55. PubMed ID: 12656676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2.
    Mikus P; Ny T
    J Biol Chem; 1996 Apr; 271(17):10048-53. PubMed ID: 8626560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
    Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
    J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the local conformational change of alpha1-antitrypsin.
    Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
    Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations.
    Wilczynska M; Lobov S; Ny T
    FEBS Lett; 2003 Feb; 537(1-3):11-6. PubMed ID: 12606023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
    Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein.
    Smolarczyk K; Gils A; Boncela J; Declerck PJ; Cierniewski CS
    Biochemistry; 2005 Sep; 44(37):12384-90. PubMed ID: 16156651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes.
    Risse BC; Chung NM; Baker MS; Jensen PJ
    J Cell Physiol; 2000 Feb; 182(2):281-9. PubMed ID: 10623892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.
    Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS
    J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-active bis-cysteinyl peptides. II. Comparative study on the sequence-dependent tendency for disulfide loop formation.
    Siedler F; Quarzago D; Rudolph-Böhner S; Moroder L
    Biopolymers; 1994 Nov; 34(11):1563-72. PubMed ID: 7827267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pancreas-specific protein disulfide isomerase homolog (PDIp) is redox-regulated through formation of an inter-subunit disulfide bond.
    Fu X; Zhu BT
    Arch Biochem Biophys; 2009 May; 485(1):1-9. PubMed ID: 19150607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enthalpy measurement using calorimetry shows a significant difference in potential energy between the active and latent conformations of PAI-1.
    Sherman WA; Blouse GE; Perron MJ; Tran T; Shore JD; Gafni A
    Biol Chem; 2005 Feb; 386(2):111-6. PubMed ID: 15843154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional structure of the somatomedin B domain of vitronectin.
    Zhou A
    Protein Sci; 2007 Jul; 16(7):1502-8. PubMed ID: 17567740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.
    Medcalf RL; Stasinopoulos SJ
    FEBS J; 2005 Oct; 272(19):4858-67. PubMed ID: 16176260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.
    Mathiasen L; Dupont DM; Christensen A; Blouse GE; Jensen JK; Gils A; Declerck PJ; Wind T; Andreasen PA
    Mol Pharmacol; 2008 Sep; 74(3):641-53. PubMed ID: 18559377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.